| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.029 | 0.6 |